S G Shchur
6PUBLICATIONS
37CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Apr 27, 2024
[Long-term efficacy and safety of divozilimab during 2-year treatment of multiple sclerosis patients in randomized double-blind placebo-controlled clinical trial BCD-132-4/MIRANTIBUS].A N Boyko, V M Alifirova, I G Lukashevich
|Aug 10, 2023
[Efficacy and safety of antiCD20 monoclonal antibody divozilimab during 48-week treatment of multiple sclerosis patients in randomized double-blind placebo-controlled clinical trial BCD-132-4/MIRANTIBUS].A N Boyko, V M Alifirova, I G Lukashevich
|Apr 21, 2023
[Efficacy and safety of divozilimab during 24-week treatment of multiple sclerosis patients in randomized double-blind placebo-controlled clinical trial BCD-132-2].A N Boyko, V M Alifirova, I G Lukashevich
|Feb 27, 2023
[Long-term Efficacy and Safety of Sampeginterferon-β1a in the Treatment of Relapsing Remitting Multiple Sclerosis: a Randomized, Double-Blind Clinical Trial 104-Week Results].A N Boyko, K Z Bakhtiyarova, O V Boyko
|Feb 17, 2022
[Efficacy and safety of sampeginterferon β-1a in the treatment of relapsing remitting multiple sclerosis: results of 52 weeks of therapy in a randomized, double-blind clinical trial].A N Boyko, O V Boyko, K Z Bakhtiyarova
|Jan 15, 2020
[Results of a phase 1 clinical study of anti-CD20 monoclonal antibody (BCD-132): pharmacokinetics, pharmacodynamics and safety].O V Boyko, A N Boyko, P A Yakovlev
Pageof 1
Frequent Collaborators
6 joint publications
A V Zinkina-Orikhan
6 joint publications
Yu N Linkova
6 joint publications
N A Totolyan
5 joint publications
S A Sivertseva
5 joint publications
L G Zaslavsky
5 joint publications
F A Khabirov
5 joint publications
N A Malkova
5 joint publications
I Ye Poverennova
5 joint publications
Ye V Parshina
4 joint publications
L N Prakhova
